Novanta Inc 10-Q for FY2026 Q3
Novanta Inc (NOVT)
10-Q
2026-11-09
For: 2026-10-02
View Original
Added on
November 09, 2026
About this 10-Q
Novanta Inc filed this 10-Q on November 9, 2026, covering the quarter ended October 2, 2026 (FY2026 Q3).
Novanta’s quarterly revenue rose 23.1% to $305.0 million, but operating income fell 36.3% to $13.9 million, as acquisition-related costs increased. Novanta completed the Riverpoint Medical acquisition for $1,200.6 million upfront, plus a $250.0 million milestone payment. AI summary
Headline figures
Quarter ended October 2, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $305.01M
- up 23.1% from $247.84M a year earlier
- Net income
- $2.02M
- down 81.1% from net income of $10.65M a year earlier
- Diluted EPS
- $0.05
- down 83.3% from $0.30 a year earlier